Welcome to the Peptide Therapeutics FoundationThe Peptide Therapeutics Foundation is a not-for-profit 501C(3), established in 2008 to promote research and development of peptide therapeutics. The Foundation and Symposium are supported by the following corporate sponsors: ChemPartner, Ferring Research Institute Inc., Ipsen Biosciences Inc., MedImmune/AstraZeneca, Novo Nordisk, the PolyPeptide Group, Zealand Pharma, and Zydus Cadila. To learn more about our corporate sponsors and board members click here. Click here to view a poster summarizing the peptide drug landscape based on a comprehensive database of therapeutic peptides that have entered human clinical studies. |
Stéphane Bolduc – CHU de Québec – Université Laval Research Center Marcello Costa – Flinders University Warren Foster – University of California, San Diego Andrew Horne – University of Edinburgh K. Joseph Hurt – University of Colorado Ursula Kaiser – Brigham and Women’s Hospital, Harvard Medical School Sarah Marshall – Monash University Kathryn Meier – Washington State University Victor Navarro – Brigham and Women’s Hospital, Harvard Medical School Willis Samson – Saint Louis University, School of Medicine John Taylor – Kansas University Medical Center Suraj Unniappan – University of Saskatchewan Henrique Veiga-Fernandes – Champalimaud Foundation Meet the 2016 Recipients
October 25-26, 2018 The 13th Annual Peptide The Salk Institute |
Click here to learn more about The Peptide Therapeutics Foundation or our Annual Peptide Therapeutics Symposium. |
